Maternal Adiponectin Decreases Placenta Nutrient Transport in Mice

Area of Science:

• Reproductive biology
• Metabolic disorders
• Endocrinology

Background:

• Obesity and gestational diabetes are linked to altered adiponectin levels.
• Adiponectin plays a role in metabolic regulation during pregnancy.
• The placenta's role in mediating adiponectin's effects on fetal development is not fully understood.

Purpose of the Study:

• To investigate the impact of elevated maternal and fetal adiponectin on placental function, fetal growth, and metabolism.
• To determine how adiponectin influences nutrient transfer in obese pregnancies.
• To explore the consequences of altered adiponectin on fetal liver development.

Main Methods:

• Utilized adiponectin-overexpressing (APNtg) and wild-type mice on normal or high-fat/high-sucrose diets.
• Administered nutrient tracers (lipid, glucose, amino acid) to pregnant dams.
• Performed global proteomics on placental and fetal liver tissues.

Main Results:

• Increased serum adiponectin (40-50%) reduced fetal growth in obese dams on a high-fat/high-sucrose diet.
• Placental nutrient uptake (glucose, lipid, amino acid) and amino acid transporter expression decreased in APNtg dams on the high-fat/high-sucrose diet.
• Fetal livers showed downregulated lipid and amino acid metabolic pathways, indicating an energy deficit.

Conclusions:

• Elevated maternal adiponectin in obese dams impairs placental nutrient transfer, leading to fetal growth restriction and altered fetal liver function.
• Maternal adiponectin levels are a primary determinant of placental function.
• Maintaining optimal adiponectin concentrations is essential to prevent pregnancy complications like fetal growth restriction.